Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Investigational New Drug Application (IND)

FDA Clears Moonlight Therapeutics to Begin Clinical Trial for Innovative Peanut...

Another Needle-Free Emergency Epinephrine Candidate to Begin Clinical Trials

Mabylon’s Drug Candidate Promises Lasting Protection for Peanut Allergy

FDA Approves LongBio’s Anti-IgE Antibody for Clinical Trials to Treat Food...

Aravax Doses First Patient in Phase 2 Peanut Allergy Clinical Trial

Nestlé Acquires Aimmune, Partners with Enterome to Develop Food Allergy and...

Aquestive Reports Positive Results from Sublingual Epinephrine Clinical Trial

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy

Your School On Our Map

Put Your School on the Map